Hellenic Open University
Ο ρόλος του μεταγραφικού παράγοντα LRF/ZBTB7A στην επιγενετική ρύθμιση του γονιδιώματος
Abstract
dc:descriptionThe fetal (HbF) to adult (HbA) hemoglobin switch is a subject of research for the therapeutic approach of β-hemoglobinopathies through the reactivation of γ-globin. Transcription factor LRF (Leukemia/lymphoma-related factor), which is encoded by the human ZBTB7A gene, has been shown to play an important role in the process of hemoglobin switch. However, the precise regulatory mechanism and the interaction between transcription factors’ recognition and binding, and epigenetic modifications of chromatin, such as DNA methylation, biochemical modifications of histone tails, and the expression of non-coding RNAs, simultaneously contributing to the regulation of β-globin genes, remain unclear. To study the effect of LRF on the epigenetic regulation of the HbF to HbA switch, stable overexpression and silencing systems of ZBTB7A were constructed. Overexpression was achieved with self-replicating episomal vectors that express the incorporated transgenes extrachromosomally, while silencing was performed with CRISPR/Cas9 genome editing technology, in human erythroleukemic K562 cells in both cases. Although K562 cells originate from an adult patient, they endogenously express fetal hemoglobin at low levels. K562 cells were induced to erythropoiesis with hemin and erythropoietin, during which a simultaneous switch of hemoglobin production from HbF to HbA is observed, making them a suitable model for this study. In addition, transgenic K562 clones were generated capable of overexpressing the epigenetic enzymes DNMT3A (DNA methyltransferase 3A) and HDAC1 (Histone deacetylase 1), in order to evaluate the activity of LRF under conditions of epigenome disruption. The following were performed: construction of recombinant episomal vectors to generate the transgenic K562 clones and then qPCR analyses to assess relative gene expression, pyrosequencing reactions to detect methylation levels at targeted genomic sites, and immunoprecipitation experiments with ChIP-Seq to identify LRF binding sites across the genome, before and after the induction of erythropoiesis. Also, lncRNAs carrying LRF binding sites were identified and further analyzed for their expression and methylation levels across CpG islands in their promoter regions. Finally, the differential expression of miRNAs was studied using NGS technology before and after K562 erythropoiesis induction.Results showed that during hemoglobin switch, LRF binds to the γ globin genes (HBG2/1) and, in cooperation with BCL11A, contributes to the repression of their transcription. LRF also binds to the lncRNA BGLT3 gene, leading to the activation of its expression, which seems to facilitate the switch from γ to β globin expression. During K562 erythropoiesis and hemoglobin switch, LRF displayed strongly elevated binding sites in the genome, >40%, and acted as a repressor of the expression of lncRNAs and miRNAs except for lncRNA DLEU1 and lncRNA BGLT3. Expression levels and methylation status of CpG islands in promoter regions of the lncRNAs studied were not always correlated. Notably, miRNAs located in the same genetic loci as lncRNAs exhibited different expression patterns, suggesting a divergent transcriptional regulatory mechanism. The findings of this study highlight the multilevel regulatory action of LRF on gene expression during the fetal to adult hemoglobin switch and are consistent with the looping model for the developmentally controlled regulation of the β-type globin genes’ expression. The elevated recognition and binding of LRF across the genome observed during erythropoiesis in K562 cells appears to be associated with increased levels of DNA methylation.
Degree
thesis:*- Grantor dc:publisher
- Hellenic Open University
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Athanasopoulou, Aikaterini
- Αθανασοπούλου, Αικατερίνη
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60039